Replies to post #92509 on NorthWest Biotherapeutics Inc (NWBO)

[highwayman4life]

A 7 patient Phase I trial with one person demonstrating a complete response for 7.5 months.

I would direct you this 60 patient Phase I/II trail where ALL prior treatments failed:

http://www.prnewswire.com/news-releases/nw-bio-presents-further-dcvax-direct-phase-i-trial-information-on-individual-patient-survival-at-ny-cancer-immunotherapy-conference-300336496.html

The top 20% of the patients in the DCVax-Direct Phase I Trial have each exceeded 2 years of survival so far, and are still alive. The longest survivor to date has reached nearly 3 years.
The top 30% of the patients in the DCVax-Direct Phase I Trial (including pancreatic, melanoma, lung, ovarian, sarcoma and other cancers) have average actual individual survival to date of 26.7 months, compared with average expected individual survival of 12.3 months.